Tefzone TZ 250mg/31.25mg Injection
Marketer
Dalcon Drugs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Tefzone TZ 250mg/31.25mg Injection
Combiflex-TZ injection (250mg/31.25mg) is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration must always be overseen by a medical professional. Consistent adherence to the prescribed regimen is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Minor side effects may include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration support recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Tefzone TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Tefzone TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Tefzone TZ 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider; please do not self-medicate.
Common Side effects of Tefzone TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tefzone TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Tefzone TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum (Tefzone TZ 250mg/31.25mg Injection) combines a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tefzone TZ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tefzone TZ, 250mg/31.25mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Tefzone TZ 250mg/31.25mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Tefzone TZ 250mg/31.25mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tefzone TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Tefzone TZ 250mg/31.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Tefzone TZ 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Tefzone TZ 250mg/31.25mg Injection :
Omit a scheduled dose of Tefzone TZ 250mg/31.25mg Injection? Seek immediate medical advice.
Facts to Know About Tefzone TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently